[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368377-105":59,"doc-detail-368377-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","advances-and-challenges-in-3d-bioprinted-cancer-models-opportunities-for-personalized-medicine-and-tissue-engineering","Advances and Challenges in 3D Bioprinted Cancer Models: Opportunities for Personalized Medicine and Tissue Engineering","","Cancer remains a leading cause of death worldwide, and patient-to-patient variability limits the effectiveness of anti-cancer drugs. Personalized medicine requires molecular and genetic screening to stratify which patients are likely to respond to specific regimens, yet reliable risk-stratification methods are still insufficient for many cancers. Advances in 3D bioprinting enable bioengineered tumor models that mimic human tissue architecture and microenvironments for high-throughput drug response testing. These models use patient-derived cells, genetic material, extracellular matrix proteins, and growth factors, supported by natural or synthetic biopolymers to promote physiologically relevant cell-cell and cell-matrix interactions.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advances-and-challenges-in-3d-bioprinted-cancer-models-opportunities-for-personalized-medicine-and-tissue-engineering/368377/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advances-and-challenges-in-3d-bioprinted-cancer-models-opportunities-for-personalized-medicine-and-tissue-engineering/368377.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is personalized medicine important for cancer treatment?","Question",{"text":113,"@type":114},"Because responses to anti-cancer drugs vary significantly across patients, personalized approaches rely on molecular and genetic screening to identify suitable patient stratifications for specific treatment regimens.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What is the role of 3D bioprinted cancer models?",{"text":118,"@type":114},"They recreate bioengineered tumor structures that mimic human tissue and microenvironment, enabling modeling and drug response testing that better reflects complex biological interactions than conventional 2D cultures.",{"name":120,"@type":111,"acceptedAnswer":121},"What materials and cell sources are used to build these 3D models?",{"text":122,"@type":114},"Patient-derived cancer and stromal cells, along with genetic material, extracellular matrix proteins, and growth factors, are combined with natural or synthetic biopolymers and printed layer-by-layer using CAD-guided bioprinting.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},368377,1790258878,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Review  \nAdvances and Challenges in 3D Bioprinted Cancer Models: Opportunities for Personalized Medicine and  \nTissue Engineering  \nSai Liu * and Pan Jin  \nAcademic Editor: Dimitrios Bikiaris  \nReceived: 24 January 2025  \nRevised: 20 March 2025  \nAccepted: 27 March 2025  \nPublished: 31 March 2025  \nCitation: Liu, S.; Jin, P. Advancesand Challenges in 3D Bioprinted Cancer Models: Opportunities for Personalized Medicine and Tissue Engineering. Polymers 2025, 17, 948 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)polym17070948  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nHealth Science Center, Yangtze University, Jingzhou 434023, China; jinpanﬂ[yman@163.com](yman@163.com)  \n* Correspondence: [liusai0188@163.com](liusai0188@163.com)  \nAbstract: Cancer is the second leading cause of death worldwide, after cardiovascular disease, claiming not only a staggering number of lives but also causing considerable health and economic devastation, particularly in less-developed countries. Therapeutic interventions are impeded by differences in patient-to-patient responses to anti-cancer drugs. A personalized medicine approach is crucial for treating speciﬁc patient groups and includes using molecular and genetic screens to ﬁnd appropriate stratiﬁcations of patients who will respond (and those who will not) to treatment regimens. However, information on which risk stratiﬁcation method can be used to hone in on cancer types and patients who will be likely responders to a speciﬁc anti-cancer agent remains elusive formost cancers. Novel developments in 3D bioprinting technology have been widely applied to recreate relevant bioengineered tumor organotypic structures capable of mimicking the human tissue and microenvironment or adequate drug responses in high-throughput screening settings. Parts are autogenously printed in the form of 3D bioengineered tissues using a computer-aided design concept where multiple layers include different cell types and compatible biomaterials to build speciﬁc conﬁgurations. Patient-derived cancer and stromal cells, together with genetic material, extracellular matrix proteins, and growth factors, are used to create bioprinted cancer models that provide a possible platform for the screening of new personalized therapies in advance. Both natural and synthetic biopolymers have been used to encourage the growth of cells and biological materials in personalized tumor models/implants. These models may facilitate physiologically relevant cell–cell and cell–matrix interactions with 3D heterogeneity resembling real tumors.  \nKeywords: 3Dbioprinting; tumor model; tumor microenvironment; personalized medicine  \n1. Introduction  \nGlobally, cancer has emerged as the predominant cause of mortality, accounting for nearly one-sixth of all deaths in 2020 . The urgency to elucidate cancer's developmental mechanisms to discover more efﬁcacious treatments is underscored by this mortality rate. The genesis and evolution of cancer are intricately linked to the heterogeneity of cancer cells and their dynamic interplay with the surrounding microenvironment. The conventional 2D culture model, characterized by a homogenous cell type and equalized nutrient and growth factor distribution, fails to capture the complexity of cellular interactions and intratumoral diversity. Consequently, data derived from 2D models diverge signiﬁcantly from in vivo conditions [1,2] . Although in vivo tumor models utilizing experimental animals are prevalent, disparities in genetics and species result in data that may not accurately mirror human tumorigenesis and progression. Additionally, these models are encumbered by  \nethical consider","cbCaiujo5DMN5ucX","https://ap.wps.com/l/cbCaiujo5DMN5ucX","pdf",5050041,34,"English","# 1. Introduction\n# 2. Technical Methods of 3D Printing\n## 2.1. Inkjet Bioprinting","[{\"question\":\"Why is personalized medicine important for cancer treatment?\",\"answer\":\"Because responses to anti-cancer drugs vary significantly across patients, personalized approaches rely on molecular and genetic screening to identify suitable patient stratifications for specific treatment regimens.\"},{\"question\":\"What is the role of 3D bioprinted cancer models?\",\"answer\":\"They recreate bioengineered tumor structures that mimic human tissue and microenvironment, enabling modeling and drug response testing that better reflects complex biological interactions than conventional 2D cultures.\"},{\"question\":\"What materials and cell sources are used to build these 3D models?\",\"answer\":\"Patient-derived cancer and stromal cells, along with genetic material, extracellular matrix proteins, and growth factors, are combined with natural or synthetic biopolymers and printed layer-by-layer using CAD-guided bioprinting.\"}]","Advances and Challenges in 3D Bioprinted Cancer Models: Opportunities for Personalized Medicine and Tissue Engineering | PDF",1790176606,86,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3b99a4bac80894ffc2f6abef5c68f25.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6a103baf79dd21362ff0fb1ebe75d8a.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/056e841f28dc64753f1ed66eb05de3f5.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88a0297e5fcf400898935131b5f3dd6b.webp",980,1385]